Edgewise Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
EWTX on Nasdaq
Location
1715 38 Th St, Boulder, CO

Insiders trading volume in the past year

Edgewise Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter A. Thompson Director, 10%+ Owner $228M +$5M +2.24% Jun 10, 2024
Orbimed Advisors Llc Director, 10%+ Owner $228M +$5M +2.24% Jan 23, 2024
Novo Holdings A/S 10%+ Owner $95.8M Sep 14, 2022
Kevin Koch President and CEO, Director $2.13M -$59.6K -2.72% Aug 12, 2024
Behrad Derakhshan Chief Business Officer $876K -$1.45M -62.4% Sep 20, 2024
Donovan Joanne M. Cmo $849K -$272K -24.3% Sep 20, 2024
Russell Alan J Chief Scientific Officer, Director $813K -$3.76M -82.2% Sep 20, 2024
John R. Moore General Counsel $527K -$2.72M -83.8% Sep 20, 2024
R. Michael Carruthers Chief Financial Officer $492K -$5.03M -91.1% Oct 11, 2024
Semigran Marc Chief Development Officer $437K Aug 12, 2024
Fox Jonathan C Director $171K +$101K +144% Jun 10, 2024
Arlene Morris Director Jun 10, 2024
Badreddin Edris Director Jun 10, 2024
Laura Brege Director Jun 10, 2024
Jonathan Root Director Jun 10, 2024

Recent Insider Transactions by Companies or Individuals for Edgewise Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.